Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants priority review to sBLA for Keytruda with chemotherapy in first-line metastatic NSCLC

July 3, 2018

NovaTarg divulges new AMPK activators for diabetes

July 3, 2018

Entyvio approved in Japan for ulcerative colitis

July 3, 2018

Glactone Pharma Development patents STAT3 inhibitors

July 3, 2018

Dafclir receives approval in Japan

July 3, 2018

Topline data reported from phase IIa trial of IRL-752 in Parkinson's disease dementia

July 3, 2018

TRIGR Therapeutics and ABL Bio collaborate in immuno-oncology

July 3, 2018

Advicenne reports preliminary phase III extension study results for ADV-7103

July 3, 2018

Phase I/II data presented for FT-2102, a mutant IDH1 inhibitor, in AML or MDS patients

July 3, 2018

Compugen announces IND clearances for BAY-1905254 and COM-701

July 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...